- Home
- CNM vs ICLR Comparison
CNM vs ICLR Comparison
Compare CNM & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNM
- ICLR
- Stock Information
- Founded
- CNM 1996
- ICLR 1990
- Country
- CNM United States
- ICLR Ireland
- Employees
- CNM N/A
- ICLR N/A
- Industry
- CNM Durable Goods
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CNM Consumer Discretionary
- ICLR Health Care
- Exchange
- CNM Nasdaq
- ICLR Nasdaq
- Market Cap
- CNM 12.7B
- ICLR 13.7B
- IPO Year
- CNM 2021
- ICLR 1998
- Fundamental
- Price
- CNM $48.68
- ICLR $175.00
- Analyst Decision
- CNM Buy
- ICLR Buy
- Analyst Count
- CNM 10
- ICLR 15
- Target Price
- CNM $59.60
- ICLR $209.93
- AVG Volume (30 Days)
- CNM 3.1M
- ICLR 1.0M
- Earning Date
- CNM 09-09-2025
- ICLR 10-22-2025
- Dividend Yield
- CNM N/A
- ICLR N/A
- EPS Growth
- CNM 7.24
- ICLR 13.11
- EPS
- CNM 2.25
- ICLR 9.73
- Revenue
- CNM $7,740,000,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- CNM $6.26
- ICLR N/A
- Revenue Next Year
- CNM $5.46
- ICLR $1.73
- P/E Ratio
- CNM $21.67
- ICLR $17.99
- Revenue Growth
- CNM 11.02
- ICLR N/A
- 52 Week Low
- CNM $38.66
- ICLR $125.10
- 52 Week High
- CNM $67.18
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- CNM 21.96
- ICLR 53.09
- Support Level
- CNM $47.82
- ICLR $164.00
- Resistance Level
- CNM $67.18
- ICLR $180.95
- Average True Range (ATR)
- CNM 1.61
- ICLR 6.38
- MACD
- CNM -2.09
- ICLR -0.99
- Stochastic Oscillator
- CNM 4.44
- ICLR 64.59
About CNM Core & Main Inc.
Core & Main Inc is a specialty distributor focusing on water, wastewater, storm drainage, and fire protection products and services. Catering to municipalities, private water companies, and contractors, it serves municipal, non-residential, and residential markets nationwide. Its diverse product line includes pipes, valves, fittings, storm drainage products, fire protection products, and meter products. Revenue is principally generated from pipes, valves, and fittings. The company operates across three construction sectors: municipal, non-residential, and residential, contributing to reliable infrastructure development nationwide.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.